Table 4

Adjusted differences between experimental groups on athlete-reported outcomes for all case analysis and sensitivity analyses

OutcomePostintervention
(3 months)
Follow-up
(5 months)
Time*CondgTime*Condg
All case analysis
 Doping willingness−0.16 (−0.30 to −0.03)0.17 (0.01)−0.02 (−0.18 to 0.14)0.02 (0.01)
 Doping moral disengagement−0.11 (−0.24 to 0.03)0.13 (0.01)0.05 (−0.10 to 0.20)0.07 (0.01)
 Doping attitudes−0.10 (−0.23 to 0.03)0.12 (0.01)0.02 (−0.18 to 0.20)0.02 (0.01)
 Doping efficacy.03 (−0.34 to 0.39)0.02 (0.01)0.17 (−0.32 to 0.67)0.09 (0.01)
 Behaviours against inadvertent doping−0.01 (−0.21 to 0.19)0.01 (0.01)0 (−0.27 to 0.27)0 (0.01)
 Antidoping knowledge0.06 (−0.18 to 0.30)0.04 (0.01)0.42 (0.08 to 0.78)0.27 (0.01)
 Perceived coach need support0.08 (−0.09 to 0.26)0.09 (0.01)0.10 (−0.13 to 0.33)0.12 (0.01)
 Perceived coach need thwarting−0.17 (−0.35 to 0.01)0.19 (0.01)0.11 (−0.12 to 0.33)0.12 (0.01)
 Need satisfaction0.13 (−0.01 to 0.28)0.14 (0.01)0.09 (−0.12 to 0.30)0.10 (0.01)
 Need frustration−0.24 (−0.41 to −0.06)0.23 (0.01)0.05 (−0.18 to 0.28)0.04 (0.01)
Sensitivity analysis
 Doping willingness−0.10 (−0.26 to 0.06)0.11 (0.01)−0.03 (−0.19 to 0.14)0.03 (0.01)
 Doping moral disengagement−0.10 (−0.24 to 0.05)0.12 (0.01)0.04 (−0.13 to 0.20)0.05 (0.01)
 Doping attitudes−0.19 (−0.34 to −0.04)0.23 (0.01)0.07 (−0.14 to 0.28)0.09 (0.01)
 Doping efficacy−0.02 (−0.48 to 0.42)0.01 (0.01)0.26 (−0.32 to 0.84)0.13 (0.01)
 Behaviours against inadvertent doping−0.13 (−0.39 to 0.13)0.11 (0.01)0.09 (−0.20 to 0.40)0.07 (0.01)
 Antidoping knowledge−0.02 (−0.34 to 0.30)0.01 (0.01)0.49 (0.11 to 0.86)0.32 (0.01)
 Perceived coach need support0.12 (−0.10 to 0.34)0.14 (0.01)0.19 (−0.07 to 0.44)0.23 (0.01)
 Perceived coach need thwarting−0.32 (−0.54 to −0.09)0.35 (0.01)0.22 (−0.01 to 0.45)0.24 (0.01)
 Need satisfaction0.19 (0.00 to 0.39)0.21 (0.01)0.07 (−0.17 to 0.30)0.07 (0.01)
 Need frustration−0.30 (−0.50 to −0.09)0.29 (0.01)0.08 (−0.17 to 0.33)0.07 (0.01)
  • Time*Cond=effect of experimental condition on the random slope of the outcome on the time variable from level 1; grey shade=CI excludes zero; g=Hedge’s g (variance in parentheses).

  • Relative to the total sample average at postintervention, Greek athletes reported lower levels of doping efficacy (MD=−0.46, 95% CI=−0.86, −0.05) and higher levels of inadvertent doping (MD=0.31, 95% CI=0.06, 0.55), whereas British athletes reported higher levels of antidoping knowledge (MD=0.33, 95% CI=0.02, 0.63). All other country effects at other time points were small and inconsistent with a meaningful effect. All country-specific effects are reported in the online supplemental file.

  • CI, credibility interval; MD, mean difference.